Kristen K. Buck

Insider Reports History

Entity
Individual
Location
110 Allen Road, 2 Nd Floor, Basking Ridge, NJ
Signature
James Nisco, Attorney-in-Fact for Kristen K. Buck
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen K. Buck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LISATA THERAPEUTICS, INC. EVP, R&D and CMO Common Stock 62.7K $184K $2.93 Oct 1, 2024 Direct
LISATA THERAPEUTICS, INC. EVP, R&D and CMO Stock Option (Right to Buy) 14K Jan 9, 2024 Direct

Insider Reports Filed by Kristen K. Buck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LSTA LISATA THERAPEUTICS, INC. Oct 1, 2024 2 $25.3K 4 Oct 2, 2024 EVP, R&D and CMO
LSTA LISATA THERAPEUTICS, INC. Jan 9, 2024 5 -$18.1K 4 Jan 11, 2024 EVP, R&D and CMO
LSTA LISATA THERAPEUTICS, INC. Sep 1, 2023 1 -$6.34K 4 Sep 5, 2023 EVP, R&D and CMO
LSTA LISATA THERAPEUTICS, INC. Jan 9, 2023 4 -$8.08K 4 Jan 11, 2023 EVP, R&D and CMO
LSTA CALADRIUS BIOSCIENCES, INC. Sep 1, 2022 3 -$5.98K 4 Sep 2, 2022 EVP, R&D and CMO
LSTA CALADRIUS BIOSCIENCES, INC. Jan 10, 2022 3 -$7.06K 4 Jan 12, 2022 EVP, R&D and CMO
LSTA CALADRIUS BIOSCIENCES, INC. Sep 1, 2021 3 -$64.1K 4 Sep 3, 2021 EVP, R&D and CMO
LSTA CALADRIUS BIOSCIENCES, INC. Sep 1, 2021 0 $0 3 Sep 3, 2021 EVP, R&D and CMO